(CercleFinance.com) – The biotechnology company Genomic Vision announced on Tuesday the appointment of Frédéric Hammel as Chief Operating Officer to strengthen its management team.
As part of his new duties, Frédéric Hammel, a biologist by training, will be in charge of managing all operational aspects of the company specializing in the analysis of genome modifications.
With over 25 years of experience in the healthcare industry, he was most recently the Managing Director of Ethera, a manufacturer of air quality analysis products.
Prior to that, he was CEO of Platine Pharma Services, an analytical services company since acquired by bioMérieux, and of TxCell, a biotechnology company developing cellular immunotherapies.
Genomic also announced on Tuesday the appointment of a new director of human resources, Claire Fleury, with the aim of supporting its workforce.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
